Masthead
About this digest
An independent editorial reading of the ipamorelin record. No clinic, no counter, no products.
What this is
Ipamorelin Pharmacy is an independent editorial project that publishes summaries of the peer-reviewed research literature and the regulatory record on ipamorelin. We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.
About the name
The word "pharmacy" in this site's name is editorial framing — a vantage point on the literature, organized around the questions of approval, scheduling, and compounding access. It is not a claim that this site is a pharmacy. Nothing here is stocked, dispensed, compounded, prescribed, or sold. Ipamorelin is not an approved pharmacy medication, and this site exists precisely to document that regulatory status plainly, not to supply the compound.
How we work
We read the primary literature — the founding pharmacology, the human pharmacokinetic study, the single Phase 2 trial, the preclinical and anti-doping work, and recent reviews — and we render it in plain language with every quantitative claim cited to its source. Where the evidence is thin or absent, we say so rather than fill the gap. Community-reported effects are presented only as labeled anecdote, kept separate from the cited science. We name no branded drug products and we recommend no human dose.
What we are not
We are not a healthcare provider, a telehealth service, a compounding pharmacy, or a supplier. We have no doctors, no pharmacists, and no clinical staff. We do not offer consultations, treatment, or prescriptions, and we do not take orders. If a page reads like a specification rather than a sales pitch, that is the intent: this is a record, not a storefront.